Figure 7.BMP4 may suppress hepatic steatosis and alleviate the development and progression of NAFLD by inhibiting mTORC1 signaling. BMP4 decrease the expression of S6K, p-S6K and SREBF1, while increase the expression of LIPIN1.
Figure 7 — Bone morphogenetic protein 4 (BMP4) alleviates hepatic steatosis by increasing hepatic lipid turnover and inhibiting the mTORC1 signaling axis in hepatocytes | Aging
